|
|
Volumn 24, Issue 2 Suppl, 2010, Pages 21-26
|
|
The antidepressant agomelatine improves the quality of life of depressed patients: implications for remission.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETAMIDE DERIVATIVE;
AGOMELATINE;
ANTIDEPRESSANT AGENT;
HUMAN;
MAJOR DEPRESSION;
METHODOLOGY;
PATHOPHYSIOLOGY;
PATIENT COMPLIANCE;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
REMISSION;
REVIEW;
ACETAMIDES;
ANTIDEPRESSIVE AGENTS;
DEPRESSIVE DISORDER, MAJOR;
HUMANS;
MEDICATION ADHERENCE;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECURRENCE;
REMISSION INDUCTION;
MLCS;
MLOWN;
|
|
EID: 78049520183
PISSN: None
EISSN: 14617285
Source Type: Journal
DOI: 10.1177/1359786810372978 Document Type: Review |
|
Times cited : (25)
|
|
References (0)
|
